Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HESS CORPHES · Entity 11019 | Director | March 06, 2021 | March 09, 2021 |
| JOHNSON & JOHNSONJNJ · Entity 2722 | Director · CEO and Chairman of the Board | August 13, 2026 | August 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HESS CORP
Report date March 06, 2021 · Filed March 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1.00 par valueSEC Table I · non-derivative | Direct | 6,392 |
Reported balance
After 2021-03-06 transaction · row 1
1 source rowRow 1 · 2021-03-06 · Grant · Acquired 2,332 · Balance 6,392 |
JOHNSON & JOHNSON
Report date August 13, 2026 · Filed August 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,967 |
Ending reported balance
After 2026-08-13 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-08-13 · Exercise / conversion · Acquired 123,291 · Balance 399,258 Row 2 · 2026-08-13 · Sale · Disposed 20,976 · Balance 378,282 Row 3 · 2026-08-13 · Sale · Disposed 102,315 · Balance 275,967 |
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $115.67 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2026-08-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-13 · Exercise / conversion · Disposed 123,291 · Balance 0 F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k | 1,018 |
Reported balance
Holding disclosure · report date 2026-08-13 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,018 F1: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/31/2026). |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 30,852 |
Reported balance
Holding disclosure · report date 2026-08-13 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 30,852 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (6/31/2026).
F2: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,513 | $150.46 | $528,565.98 |
DisclosureSEC source: 0001225208-20-002660 · doc4.xml · nonDerivative · entry 4 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,860 F4 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 10,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002660 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 24,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002660 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 70,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002660 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Retention Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,220 Underlying: Common Stock · 5,220 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 24,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,561 Underlying: Common Stock · 24,561 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F2 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 133,516 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002106 · doc4.xml · derivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,516 Underlying: Common Stock · 133,516 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 10 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,424 Underlying: Common Stock · 5,424 shares Expires not disclosed F8 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F8 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 22,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 9 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 110,868 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,868 Underlying: Common Stock · 110,868 shares Expires 2029-02-11 F7 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 11,435 | $131.94 | $1,508,733.90 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 5 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,705 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 3,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 4 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,140 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 22,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 9,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,049 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 2,798 | $132.00 | $369,336.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,806 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 9,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002347 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 5,130 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,130 shares Expires 2019-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 15,577 | $0.00 Strike: $65.37 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,423 Underlying: Common Stock · 15,577 shares Expires 2022-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 19,293 | $0.00 Strike: $62.20 | $0.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,293 shares Expires 2021-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 40,000 | $144.36 | $5,774,480.00 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 4 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,555 F1 · price: This transaction was executed in multiple trades at prices ranging from $144.31 to $144.484. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 5,130 | $58.33 | $299,232.90 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 15,577 | $65.37 | $1,018,268.49 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 22:20 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 19,293 | $62.20 | $1,200,024.60 |
DisclosureSEC source: 0001225208-18-015372 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,283 Underlying: Common Stock · 5,283 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 24,530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 105,307 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,307 Underlying: Common Stock · 105,307 shares Expires 2028-02-12 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 14,486 | $129.51 | $1,876,081.86 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,555 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 8,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,041 F2 · shares: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 24,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002947 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:54 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 9,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002808 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:54 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,668 | $128.18 | $470,164.24 |
DisclosureSEC source: 0001225208-18-002808 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,680 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:54 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 9,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002808 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,842 | $0.00 Strike: $61.75 | $0.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,842 shares Expires 2018-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 29,158 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,130 Underlying: Common Stock · 29,158 shares Expires 2019-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 50,000 | $123.62 | $6,181,140.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,536 F1 · price: This transaction was executed in multiple trades at prices ranging from $123.35 to $123.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 20,842 | $61.75 | $1,286,993.50 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 29,158 | $58.33 | $1,700,786.14 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRetention Restricted Share Units · Derivative | 70,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 8 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,733 Underlying: Common Stock · 70,733 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 10,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 7 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,374 Underlying: Common Stock · 10,374 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 22,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,298 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 123,291 | $0.00 Strike: $115.67 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,291 Underlying: Common Stock · 123,291 shares Expires 2027-02-13 F5 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 16,175 | $115.67 | $1,870,962.25 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,536 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 8,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,711 F2 · shares: Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 22,298 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003498 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 8,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 3,363 | $115.13 | $387,182.19 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,516 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 8,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003259 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 10, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.